Niazi, S. K. (2025). Continuous Manufacturing of Recombinant Drugs: Comprehensive Analysis of Cost Reduction Strategies, Regulatory Pathways, and Global Implementation. Pharmaceuticals. https://doi.org/10.3390/ph18081157
Copiat
No s'ha pogut copiar
Cita Chicago (17th ed.)
Niazi, Sarfaraz K. "Continuous Manufacturing of Recombinant Drugs: Comprehensive Analysis of Cost Reduction Strategies, Regulatory Pathways, and Global Implementation."
Pharmaceuticals 2025. https://doi.org/10.3390/ph18081157.
Copiat
No s'ha pogut copiar
Cita MLA (9th ed.)
Niazi, Sarfaraz K. "Continuous Manufacturing of Recombinant Drugs: Comprehensive Analysis of Cost Reduction Strategies, Regulatory Pathways, and Global Implementation."
Pharmaceuticals, 2025, https://doi.org/10.3390/ph18081157.
Copiat
No s'ha pogut copiar
Atenció: Aquestes cites poden no estar 100% correctes.